Giving Them a Sicko Feeling Lillygate Harry and Louise Republican controlled FDA

Giving Them a Sicko Feeling Lillygate Harry and Louise Republican controlled FDA

The GOP is heavy into pharmaceuticals the administration has a Lillygate in the Bushes
http://www.google.com/search?sourceid=navclient&ie=UTF-8&rls=GGLD,GGLD:2004-15,GGLD:en&q=Bush+Lilly

and Rumsfeld a Monsanto-Searl Aspartame Bextra Valdecoxib pusher guy. http://www.google.com/search?hl=en&q=Rumsfeld+Searle+Bextra+Aspartame&spell=1

Eugenics and the Republican controlled FDA
http://raenergy.igc.org/esa.html

The harry and Louise fiasco in the Clinton era should be the window into the CREEPing fascism of phamacopia. Click on groups for more
http://www.google.com/search?sourceid=navclient&ie=UTF-8&rls=GGLD,GGLD:2004-15,GGLD:en&q=Harry+and+Louise+raenergy

The profits in the pharmaceutical war against the people are interesting.
http://raenergy.igc.org/Pharma_Report.pdf

Bush To Impose Psychiatric Drug Regime With Zyprexa bieng the Lilly Lulu it makes sense.

http://www.newmediaexplorer.org/sepp/2004/06/23/bush_to_impose_psychiatric_drug_regime.htm




Los Angeles Times
December 22, 2004

Giving them a sick feeling

Drug firms are on the defense as filmmaker
Michael Moore plans to dissect their industry.
http://www.calendarlive.com/movies/cl-et-sicko22dec22,0,6802866.story

By Elaine Dutka Times Staff Writer

America's pharmaceutical industry is putting out an
advisory about the latest potential threat to its
health: Michael Moore.

Moore, the filmmaker whose targets have included
General Motors ("Roger & Me"), the gun lobby (the
Oscar-winning "Bowling for Columbine") and President
Bush ("Fahrenheit 9/11") has now set his sights on the
healthcare industry, including insurance companies,
HMOs, the Food and Drug Administration - and drug
companies.

At least six of the nation's largest firms have already
issued internal notices to their workforces, preparing
them for potential ambushes.

"We ran a story in our online newspaper saying Moore is
embarking on a documentary - and if you see a scruffy
guy in a baseball cap, you'll know who it is," said
Stephen Lederer, a spokesman for Pfizer Global Research
and Development.

In September and October, GlaxoSmithKline, the second-
largest in retail sales, as well as AstraZeneca and
Wyeth, sent out Moore alerts, instructing employees
that questions posed by the media or filmmakers should
be handled by corporate communications. Heavyweights
Sanofi-Synthelabo and Aventis Pharmaceuticals each sent
out similar memos before their recent merger. Merck &
Co., Abbott Laboratories, Eli Lilly & Co., Bristol-
Myers Squibb, Novartis Pharmaceuticals and Teva
Pharmaceutical Industries send periodic messages about
dealing with the press but haven't singled out Moore by
name. Johnson & Johnson declined to comment.

Moore's project is only the latest bit of bad news for
the embattled industry. Popular - and lucrative - drugs
such as Vioxx, Celebrex and Aleve have been linked to
cardiovascular problems, and the possibility of
lawsuits is looming. Canada is undercutting U.S. drug
prices, and health budgets are being slashed. And then
there's increased scrutiny by the FDA, whose oversight
of the drug industry and its relationship to it is
raising many questions.

"We have an image problem - not only with Michael
Moore, but with the general public," said M.J.
Fingland, senior director of communications for the
Washington, D.C.-based Pharmaceutical Research and
Manufacturers of America. "We're criticized on the Hill
and in the press - put in the category of the tobacco
industry, even though we save lives."

The industry, Fingland said, has made great strides in
the last three years - ever since a new ethics policy
was implemented in 2001. Drawn up with the help of the
American Medical Assn. and other medical specialty
groups, it restricted the types of gifts given to
doctors, for example, setting a $100 ceiling on each.
Although pharmaceutical companies can still sponsor
meetings, they no longer have free rein to treat
doctors to five-star dinners or pick up their hotel
tabs.

"Giveaways, lavish trips are a thing of the past,"
Fingland said. "We've cleaned up the business
considerably."

Despite the improvement, pharmaceutical executives are
bracing for the worst.

"Moore's past work has been marked by negativity, so we
can only assume it won't be a fair and balanced
portrayal," said Rachel Bloom, executive director of
corporate communications for the Wilmington, Del.-based
AstraZeneca. "His movies resemble docudramas more than
documentaries."

Rumors are already flying within the industry about
Moore's moviemaking tactics. Moore, it is said, has
hired actors to portray pharmaceutical salesmen who
offer gifts to doctors who promote their products.
There's also word that he's offered physicians $50,000
apiece to install secret cameras in their offices in an
effort to document alleged corruption.

In September, employees said that Moore was shoving a
microphone at people at GlaxoSmithKline, Bloom notes,
even though he was in town only for a radio appearance.

"We have six business centers nationwide, all of which
report 'sightings,' " Bloom said. "Michael Moore is
becoming an urban legend."

Tentatively titled "Sicko," Moore's film will probably
be released in the first half of 2006, sometime between
the Sundance and Cannes film festivals. No deal has yet
been reached, but an announcement is expected after the
new year. There's interest in the industry, he says, on
the part of some of the major studios and not just
their specialty divisions.

Reached at his home in Michigan, the director declined
to say whether he's hired actors to portray
pharmaceutical salesmen and denied paying doctors to
help him install secret cameras. ("I didn't need to. So
many doctors have offered to help, for free, in an
effort to expose the system.") He does admit to hanging
around hospitals, insurance companies and
pharmaceutical companies, including two that have not
issued internal alerts.

It's getting harder and harder to find corporate
executives, however, who are willing to sit down for
interviews, Moore said.

Moore decided to make a film about healthcare because
it's "a hot-button issue with the average American -
the domestic issue of the day," he said. "Being screwed
by your HMO and ill-served by pharmaceutical companies
is the shared American experience. The system, inferior
to that of much poorer nations, benefits the few at the
expense of the many."

Tackling the health industry first occurred to the
documentarian after he shot a segment for his now-
defunct TV show, "The Awful Truth," about a man
fighting his insurance company to pay for a kidney and
pancreas transplant. He said the viewer response was
enormous - as was audience reaction to a derogatory
line about HMOs in the Jack Nicholson-Helen Hunt movie,
"As Good As It Gets." There was a raw nerve, he
ultimately decided, that wasn't being addressed.

Last summer, the Endeavor agency, which represents
Moore, tested the Hollywood waters - sending out a six-
page outline of "Sicko" to a host of independent
producers, independent film companies and the major
studios. The movie, according to the treatment, would
end with Moore sailing to Cuba with ailing Americans to
take advantage of that country's free healthcare. That,
he says, was only a joke made on a late-night talk
show.

According to the summary, human interest stories about
victims of the system will be interspersed with
interviews. He will dig up conflict-of-interest
concerns aimed at members of Congress overseeing
Medicare and will look at politicians who accept
campaign contributions from a host of insurance
companies, as well as concerns about the "merger mania"
in the healthcare industry.

Nancy Pekarek, vice president of corporate media
relations for British firm GlaxoSmithKline, said
employees are uneasy about an assault.

"We've been getting voicemail messages," she said.
"This is their career, after all, and it's no fun to be
targeted. The problem is that Moore's film [isn't
likely to] reflect the stringent standards of today."

The movie, Moore said, is only in its early stages "and
already people are freaky-deaky."

While "Sicko" is coming to life, "Fahrenheit" hasn't
been laid to rest. Beginning on Inauguration Day, Moore
will be documenting the activities of the Bush
administration for "Fahrenheit 9/11 1/2 ."

"The word is out to whistle-blowers, in networks and
corporations, that Bush has his sequel - a second
term," Moore said. "And one bad sequel deserves a good
one. What form it takes depends on the 'improvisation'
of my lead actor. I'm more than happy to share
residuals with him if he'd sit down with me for 10
minutes."

Copyright 2004 Los Angeles Times

http://www.calendarlive.com/movies/cl-et-sicko22dec22,0,6802866.story



Ra Energy Fdn.
Raleigh Myers
Worksheet bio
http://raenergy.igc.org/bio.html
Blog
http://raenergy.blogspot.com/

Call to Action blog a virtual seminar for change
http://www.google.com/search?q=Global+Vote+raenergy&hl=en&lr=&ie=UTF-8&oe=UTF-8&filter=02Eigc%2Eorg%2Faction%2Ehtml

Newsgroups beginning in the eighties click on date and web
http://groups.google.com/groups?sourceid=navclient&ie=UTF-8&q=%22Ra+Energy+Fdn%2E%22

Never doubt that a small group of thoughtful, committed citizens can change the world. Indeed, it's the only thing that ever has. - - Margaret Mead